Ted Love

Ted Love

DirectoratStructure Therapeutics· In proxies 2023–2025

Ted Love sits on 7 public boards.

Boards1

  • Structure TherapeuticsDirector · 2 yr on the boardIndependentCompensation (Chair), Research & Development—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Structure TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -17%
  2. Gilead Sciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Jazz PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  4. Royalty Pharma PlcPublic company
    • Director? – PresentNo stock prices for these years
  5. Seagen, Inc.Public company · 3 yr
    • Director2020 – 2023 · 3 yrNo stock prices for these years
  6. Portola Pharmaceuticals, Inc.Public company · 1 yr
    • Director2019 – 2020 · 1 yrNo stock prices for these years
  7. Amicus Therapeutics, Inc.Public company · 8 yr
    • Director2012 – 2020 · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?